Cargando…
Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder
BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) and exposure with response prevention for treatment of obsessive-compulsive disorder (OCD) have demonstrated empirical support; however, a substantial number of patients remain with clinically significant OCD symptoms after such treatments....
Autores principales: | Vakili, Yaghoob, Gharaee, Banafsheh, Habibi, Mojtaba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mazandaran University of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539588/ https://www.ncbi.nlm.nih.gov/pubmed/26288647 http://dx.doi.org/10.17795/ijpbs845 |
Ejemplares similares
-
The Effectiveness of Acceptance and Commitment Therapy in Treating a Case of Obsessive Compulsive Disorder
por: Vakili, Yaghoob, et al.
Publicado: (2014) -
Relationship Between Cognitive Fusion, Experiential Avoidance, and Obsessive–Compulsive Symptoms in Patients With Obsessive–Compulsive Disorder
por: Xiong, Ai, et al.
Publicado: (2021) -
Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
por: Shahini, Najmeh, et al.
Publicado: (2021) -
Is Acceptance and Commitment Therapy Effective for Any Obsessive-Compulsive Symptom Dimensions?
por: Lee, Sang Won, et al.
Publicado: (2023) -
Experience of Disgust and Symptom Severity in Contamination Subtype of Obsessive-Compulsive Disorder: Role of Experiential Avoidance
por: D’Mello, Raina Jane, et al.
Publicado: (2022)